[{"NetIncomeLoss_1_Q3_USD":-22489000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-110000.0,"LongTermDebtCurrent_0_Q3_USD":0.0,"LongTermDebt_0_Q3_USD":4944000.0,"AssetsCurrent_0_Q3_USD":274934000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2928000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1960374.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":37215000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":0.0,"InterestPaidNet_3_Q3_USD":173000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":11173000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GeneralAndAdministrativeExpense_1_Q3_USD":5881000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":15988000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":4.87,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":1907000.0,"ContractWithCustomerLiability_0_Q3_USD":3998000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6995704.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":6.17,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":0.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":6995704.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":11343000.0,"ShareBasedCompensation_3_Q3_USD":5183000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-2000.0,"Assets_0_Q3_USD":290128000.0,"CommonStockSharesIssued_0_Q3_shares":68470081.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":29000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":30000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2843000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":317000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6995704.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":84000.0,"OperatingLeaseLiability_0_Q3_USD":11886000.0,"FinanceLeaseLiability_0_Q3_USD":291000.0,"RetainageDeposit_0_Q3_USD":1832000.0,"CommonStockValue_0_Q3_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.81,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.72,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2367000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":68419192.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":59086202.0,"FinanceLeasePrincipalPayments_3_Q3_USD":87000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-2000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-25000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":37500000.0,"DebtInstrumentUnamortizedPremium_0_Q3_USD":6000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":16051000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":6.52,"ResearchAndDevelopmentExpense_1_Q3_USD":16546000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":44179000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q3_security":0.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_3_Q3_USD":0.0,"DepreciationDepletionAndAmortization_3_Q3_USD":750000.0,"ContractWithCustomerAssetNet_0_Q3_USD":0.0,"Liabilities_0_Q3_USD":36820000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":504876000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":10606000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":270936000.0,"OtherAssetsNoncurrent_0_Q3_USD":2153000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.004,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.013,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":4165000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-2766000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-59228000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-22489000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-59203000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":116000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":39474.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":321000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":228747000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-22491000.0,"DeferredFinanceCostsNet_0_Q3_USD":262000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2460000.0,"CommonStockSharesAuthorized_0_Q3_shares":175000000.0,"NonoperatingIncomeExpense_1_Q3_USD":-73000.0,"NonoperatingIncomeExpense_3_Q3_USD":147000.0,"AccountsPayableCurrent_0_Q3_USD":4528000.0,"LiabilitiesCurrent_0_Q3_USD":21070000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2772000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":68419192.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":59086202.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-57377000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1918000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":7.7,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":127709.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":0.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":11000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":817000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q3_USD":0.0,"InterestExpense_3_Q3_USD":267000.0,"InterestExpense_1_Q3_USD":92000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":271257000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":333000.0,"NetIncomeLoss_3_Q3_USD":-59203000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1698000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":1213000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":338069.0,"SecurityDeposit_0_Q3_USD":321000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-22489000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-59203000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":74000.0,"InterestExpenseDebt_1_Q3_USD":60000.0,"InterestExpenseDebt_3_Q3_USD":173000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":65000.0,"LongTermDebtNoncurrent_0_Q3_USD":4944000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1732000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3998000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":700000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":604000.0,"RestrictedCashNoncurrent_0_Q3_USD":321000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":2080000.0,"PreferredStockSharesAuthorized_0_Q3_shares":25000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3647000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":290128000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":5.13,"PreferredStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.41,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":3998000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"InvestmentIncomeInterest_1_Q3_USD":19000.0,"InvestmentIncomeInterest_3_Q3_USD":414000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":11000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":817000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":5183000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1918000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1280000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":208585000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-251575000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":3256514.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6215368.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":86000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":5200000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":285000.0,"CommonStockSharesOutstanding_0_Q3_shares":68470081.0,"StockholdersEquity_0_Q3_USD":253308000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":200000.0,"ProfitLoss_3_Q3_USD":-59203000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.33,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":9980000.0,"OperatingExpenses_1_Q3_USD":22427000.0,"OperatingExpenses_3_Q3_USD":60167000.0,"OtherLiabilitiesCurrent_0_Q3_USD":91000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-817000.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]